Acorah Software Products - Accounts Production 16.6.950 false true false true No description of principal activity 15 March 2024 31 March 2025 31 March 2025 15564457 Mr. Jonathan Belshaw iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15564457 2024-03-14 15564457 2025-03-31 15564457 2024-03-15 2025-03-31 15564457 frs-core:CurrentFinancialInstruments 2025-03-31 15564457 frs-bus:PrivateLimitedCompanyLtd 2024-03-15 2025-03-31 15564457 frs-bus:FilletedAccounts 2024-03-15 2025-03-31 15564457 frs-bus:Micro-entities 2024-03-15 2025-03-31 15564457 frs-bus:AuditExempt-NoAccountantsReport 2024-03-15 2025-03-31 15564457 frs-bus:Director1 2024-03-15 2025-03-31
Registered number: 15564457
XII TRIALS LTD
Unaudited Financial Statements
For the Period 15 March 2024 to 31 March 2025
Balance Sheet
Registered number: 15564457
31 March 2025
£
Fixed assets 3,352
Current assets 5,900
Creditors: Amounts Falling Due Within One Year (28,756 )
NET CURRENT LIABILITIES (22,856 )
TOTAL ASSETS LESS CURRENT LIABILITIES (19,504 )
Accruals and deferred income (396 )
NET LIABILITIES (19,900 )
CAPITAL AND RESERVES (19,900 )

Notes

1. General Information
XII TRIALS LTD is a private company, limited by shares, incorporated in England & Wales, registered number 15564457 . The registered office is Flat 22 11 Lambarde Square, London, SE10 9GF.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr. Jonathan Belshaw
Director
11/12/2025